• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » MCRC Buyback Spurs 250% Revenue Growth

MCRC Buyback Spurs 250% Revenue Growth

August 12, 2008
CenterWatch Staff

Multispecialty clinical research site Metroplex Clinical Research Center (MCRC) reported last week that gross revenues have increased 250% since company executives re-assumed control in March 2007.

Radiant Research, a Seattle-based site management organization (SMO), acquired the company in 1999, but Radiant’s recent efforts to divest some of its smaller sites gave the previous physician owners an opportunity to purchase it back, said Chad Fragle, MCRC’s chief executive officer. Fragle wouldn’t provide specific numbers, but stated that the number of employees and ongoing trials have also increased, although not by as big a percentage.

Diana Anderson, president and chief executive officer of patient recruitment and retention provider D. Anderson & Company, partnered with MCRC medical directors to facilitate the repurchase. This ongoing partnership and the resulting buyback are at least indirectly responsible for MCRC’s recent success, Fragle said, because site physicians are more invested in the company’s success.

“We have a group of 10 rheumatologists that really help to support the clinical research process. We involve those physicians in the actual research perspective. I think having an ownership stake in it really makes a difference,” Fragle said.

MCRC’s physicians have also become more involved in phase I research in the last year, which has contributed to the Dallas-based site’s growth, Fragle stated.

“The fact that we did buy it back and kind of controlled our own destiny enabled us to make a foray into phase I, while we still have quite a few phase II, III, and IV studies,” Fragle said.

MCRC’s phase I projects will continue to increase, particularly in the area of musculoskeletal, Fragle predicted. “Musculoskeletal phase I has really increased just in the past six months, and we continue to get new trials coming our way. The physicians are very interested in it.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing